UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CONTROL: A randomized phase 2 study of obeticholic acid and atorvastatin on lipoproteins in nonalcoholic steatohepatitis patients

Liver international, 2019-11, Vol.39 (11), p.2082-2093

2019

Volltextzugriff (PDF)

Plain language summary of safety and symptom improvement with vibegron in people with overactive bladder: results from the EMPOWUR study

Journal of comparative effectiveness research, 2023-09, Vol.12 (9), p.CER-CER

2023

Volltextzugriff (PDF)

Plain language summary: does treatment with vibegron result in improvements in overactive bladder (OAB) symptoms that are meaningful to people with OAB?

Journal of comparative effectiveness research, 2023-09, Vol.12 (9), p.CER-CER

2023

Volltextzugriff (PDF)

The effect of a thiazolidinedione drug, troglitazone, on glycemia in patients with type 2 diabetes mellitus poorly controlled with sulfonylurea and metformin. A multicenter, randomized, double-blind, placebo-controlled trial

Annals of internal medicine, 2001-05, Vol.134 (9 Pt 1), p.737

2001

Volltextzugriff (PDF)

Reply: Letter: Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 COURAGE Trial

The Journal of urology, 2024-10, p.101097JU0000000000004291

2024

Volltextzugriff (PDF)

The hsp90-binding Antibiotic Geldanamycin Decreases Raf Levels and Epidermal Growth Factor Signaling without Disrupting Formation of Signaling Complexes or Reducing the Specific Enzymatic Activity of Raf Kinase

The Journal of biological chemistry, 1997-02, Vol.272 (7), p.4013-4020

1997

Volltextzugriff (PDF)

Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 Randomized Controlled COURAGE Trial

The Journal of urology, 2024-08, Vol.212 (2), p.256-266

2024

Volltextzugriff (PDF)

PD54-12 EFFECT OF VIBEGRON ON QUALITY OF LIFE IN MEN WITH BENIGN PROSTATIC HYPERPLASIA AND SYMPTOMS OF OVERACTIVE BLADDER: PATIENT-REPORTED OUTCOMES FROM THE PHASE 3 RANDOMIZED CONTROLLED COURAGE TRIAL

The Journal of urology, 2024-05, Vol.211 (5S)

2024

Volltextzugriff (PDF)

P2-12 EFFICACY AND SAFETY OF VIBEGRON IN MEN WITH BENIGN PROSTATIC HYPERPLASIA AND SYMPTOMS OF OVERACTIVE BLADDER: RESULTS FROM THE PHASE 3 RANDOMIZED CONTROLLED COURAGE TRIAL

The Journal of urology, 2024-05, Vol.211 (5S2)

2024

Volltextzugriff (PDF)

A Model of Protein Targeting Mediated by Immunophilins and Other Proteins That Bind to hsp90 via Tetratricopeptide Repeat Domains

The Journal of biological chemistry, 1996-06, Vol.271 (23), p.13468-13475

1996

Volltextzugriff (PDF)

The Cyclosporin A-binding Immunophilin CyP-40 and the FK506-binding Immunophilin hsp56 Bind to a Common Site on hsp90 and Exist in Independent Cytosolic Heterocomplexes with the Untransformed Glucocorticoid Receptor (∗)

The Journal of biological chemistry, 1995-09, Vol.270 (35), p.20479-20484

1995

Volltextzugriff (PDF)

Binding of Immunophilins to the 90 kDa Heat Shock Protein (hsp90) via a Tetratricopeptide Repeat Domain Is a Conserved Protein Interaction in Plants

Biochemistry (Easton), 1996-12, Vol.35 (48), p.15249-15255

1996

Volltextzugriff (PDF)

The 23-kDa Acidic Protein in Reticulocyte Lysate Is the Weakly Bound Component of the hsp Foldosome That Is Required for Assembly of the Glucocorticoid Receptor into a Functional Heterocomplex with hsp90 (∗)

The Journal of biological chemistry, 1995-08, Vol.270 (32), p.18841-18847

1995

Volltextzugriff (PDF)

Mo1455 - Disease Severity, Obeticholic Acid Disposition and dose Selection with Biliary Atresia

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-1212-S-1212

2018

Volltextzugriff (PDF)

A Plain Language Summary on the Effect of the Medication Vibegron on Blood Pressure and Heart Rate in People With Overactive Bladder

Future cardiology, 2023-06, Vol.19 (7), p.363-370

2023

Volltextzugriff (PDF)

Characterization of the protein-protein interactions determining the heat shock protein (hsp90.hsp70.hsp56) heterocomplex

The Journal of biological chemistry, 1994-04, Vol.269 (15), p.11155-11161

1994

Volltextzugriff (PDF)

Reconstitution of the Steroid Receptor·hsp90 Heterocomplex Assembly System of Rabbit Reticulocyte Lysate

The Journal of biological chemistry, 1996-05, Vol.271 (22), p.12833-12839

1996

Volltextzugriff (PDF)

Protein Phosphatase 5 Is a Major Component of Glucocorticoid Receptor·hsp90 Complexes with Properties of an FK506-binding Immunophilin

The Journal of biological chemistry, 1997-06, Vol.272 (26), p.16224-16230

1997

Volltextzugriff (PDF)

The hsp56 immunophilin component of untransformed steroid receptor complexes is localized both to microtubules in the cytoplasm and to the same nonrandom regions within the nucleus as the steroid receptor

Molecular endocrinology (Baltimore, Md.), 1994-12, Vol.8 (12), p.1731-1741

1994

Volltextzugriff (PDF)

The native v-Raf/hsp90/p50 heterocomplex contains a novel immunophilin of the FK506 binding class

The Journal of biological chemistry, 1994-09, Vol.269 (35), p.22157-22161

1994

Volltextzugriff (PDF)

Evidence for a universal TPR binding domain onhsp90

Owens-Grillo, Janet K

1996

Volltextzugriff (PDF)

Reconstitution of the Steroid ReceptorÂ·hsp90 Heterocomplex Assembly System of Rabbit Reticulocyte Lysate

The Journal of biological chemistry, 1996-05, Vol.271 (22), p.12833

1996

Volltextzugriff (PDF)

Protein Phosphatase 5 Is a Major Component of Glucocorticoid ReceptorÂ·hsp90 Complexes with Properties of an FK506-binding Immunophilin

The Journal of biological chemistry, 1997-06, Vol.272 (26), p.16224

1997

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(22)
Dissertationen
(1)

Sprache

Englisch
(23)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

CONTROL: A randomized phase 2 study of obeticholic acid and atorvastatin on lipoproteins in nonalcoholic steatohepatitis patients

Plain language summary of safety and symptom improvement with vibegron in people with overactive bladder: results from the EMPOWUR study

Plain language summary: does treatment with vibegron result in improvements in overactive bladder (OAB) symptoms that are meaningful to people with OAB?

The effect of a thiazolidinedione drug, troglitazone, on glycemia in patients with type 2 diabetes mellitus poorly controlled with sulfonylurea and metformin. A multicenter, randomized, double-blind, placebo-controlled trial

Reply: Letter: Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 COURAGE Trial

The hsp90-binding Antibiotic Geldanamycin Decreases Raf Levels and Epidermal Growth Factor Signaling without Disrupting Formation of Signaling Complexes or Reducing the Specific Enzymatic Activity of Raf Kinase

Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 Randomized Controlled COURAGE Trial

PD54-12 EFFECT OF VIBEGRON ON QUALITY OF LIFE IN MEN WITH BENIGN PROSTATIC HYPERPLASIA AND SYMPTOMS OF OVERACTIVE BLADDER: PATIENT-REPORTED OUTCOMES FROM THE PHASE 3 RANDOMIZED CONTROLLED COURAGE TRIAL

P2-12 EFFICACY AND SAFETY OF VIBEGRON IN MEN WITH BENIGN PROSTATIC HYPERPLASIA AND SYMPTOMS OF OVERACTIVE BLADDER: RESULTS FROM THE PHASE 3 RANDOMIZED CONTROLLED COURAGE TRIAL

A Model of Protein Targeting Mediated by Immunophilins and Other Proteins That Bind to hsp90 via Tetratricopeptide Repeat Domains

The Cyclosporin A-binding Immunophilin CyP-40 and the FK506-binding Immunophilin hsp56 Bind to a Common Site on hsp90 and Exist in Independent Cytosolic Heterocomplexes with the Untransformed Glucocorticoid Receptor (∗)

Binding of Immunophilins to the 90 kDa Heat Shock Protein (hsp90) via a Tetratricopeptide Repeat Domain Is a Conserved Protein Interaction in Plants

The 23-kDa Acidic Protein in Reticulocyte Lysate Is the Weakly Bound Component of the hsp Foldosome That Is Required for Assembly of the Glucocorticoid Receptor into a Functional Heterocomplex with hsp90 (∗)

Mo1455 - Disease Severity, Obeticholic Acid Disposition and dose Selection with Biliary Atresia

A Plain Language Summary on the Effect of the Medication Vibegron on Blood Pressure and Heart Rate in People With Overactive Bladder

Characterization of the protein-protein interactions determining the heat shock protein (hsp90.hsp70.hsp56) heterocomplex

Reconstitution of the Steroid Receptor·hsp90 Heterocomplex Assembly System of Rabbit Reticulocyte Lysate

Protein Phosphatase 5 Is a Major Component of Glucocorticoid Receptor·hsp90 Complexes with Properties of an FK506-binding Immunophilin

The hsp56 immunophilin component of untransformed steroid receptor complexes is localized both to microtubules in the cytoplasm and to the same nonrandom regions within the nucleus as the steroid receptor

The native v-Raf/hsp90/p50 heterocomplex contains a novel immunophilin of the FK506 binding class

Evidence for a universal TPR binding domain onhsp90

Reconstitution of the Steroid ReceptorÂ·hsp90 Heterocomplex Assembly System of Rabbit Reticulocyte Lysate

Protein Phosphatase 5 Is a Major Component of Glucocorticoid ReceptorÂ·hsp90 Complexes with Properties of an FK506-binding Immunophilin

Suchergebnisse filtern